Telehealth-enhanced Hybrid CR for Acute Coronary Syndrome
Columbia University Irving Medical Center, New York, NY
Targeting 2 different conditionsTelehealth-enhanced Hybrid CR +1 moreN/ARecruitingLed by Andrea T Duran, PhDResearch Sponsored by Columbia UniversityEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upbaseline and 3-month post program completion
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will compare the effects of telehealth-enhanced hybrid cardiac rehabilitation (THCR) versus traditional cardiac rehabilitation (CR) on ACS survivors.
Eligible Conditions
- Acute Coronary Syndrome
- Heart Attack
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 3-month post program completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3-month post program completion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean proportion of CR sessions completed by participants allocated to the THCR intervention
Number of participants who are successfully enrolled into the pilot study per month
Secondary outcome measures
Mean proportion of CR sessions completed by those allocated to the traditional CR intervention
Proportion of participants that attend ≥1 CR session after randomization in each arm
Proportion of participants who report adequate feasibility of the THCR intervention
Other outcome measures
Change in health-related quality of life score
Change in total distance traveled in 6MWT
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth-enhanced Hybrid CRExperimental Treatment1 Intervention
Participants will receive a hybrid version of cardiac rehabilitation.
Group II: Traditional CRActive Control1 Intervention
Participants will receive a standard of care version of cardiac rehabilitation.
Find a site
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,381 Previous Clinical Trials
1,836,068 Total Patients Enrolled
9 Trials studying Acute Coronary Syndrome
3,712 Patients Enrolled for Acute Coronary Syndrome
National Institutes of Health (NIH)NIH
2,611 Previous Clinical Trials
6,663,298 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
440 Patients Enrolled for Acute Coronary Syndrome
Andrea T Duran, PhDPrincipal Investigator
Columbia University1 Previous Clinical Trials
4 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
4 Patients Enrolled for Acute Coronary Syndrome
Daichi Shimbo, MDStudy Director
Columbia University2 Previous Clinical Trials
491 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scope of enrollment for this clinical research study?
"Affirmative. The information found at clinicaltrials.gov verifies that this trial is still open to new participants, having been first published on March 11th 2022 and last updated in May 4th 2022. 40 individuals are needed from 1 location for the study's completion."
Answered by AI
Are investigators currently enrolling participants in this investigation?
"The information on clinicaltrials.gov reveals that this scientific endeavor is actively recruiting volunteers. It was originally launched on March 11th 2022 and the latest update to its profile occurred on May 4th 2022."
Answered by AI
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Columbia University Irving Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies